{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:11:57Z","timestamp":1790863917500,"version":"4.1.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,24]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Synovial fluid (SF) levels of soluble CD23 (sCD23) were determined in 96 patients presenting with an inflammatory knee effusion (73 with RA and 23 with reactive arthritis (ReA) serving as a control inflammatory non-erosive group) and were correlated with the degree of joint destruction, with local immune parameters (IL-1\u03b2, IL-3, IL-4, IL-6, IL-8, IL-10, IL-12 and sCD25) and with serum markers of inflammation, C-reactive protein and erythrocyte sedimentation rate. RA patients, classified as erosive or not according to Larsen\u2019s grade, were separated as follows: (i) 13 patients with non-erosive RA; (ii) 16 RA patients with erosions in hands but not in knees, matched for disease duration with the first group; (iii) 44 RA patients with hand and knee erosions, matched with the second group for rheumatoid factor positivity but of longer disease duration. SF sCD23 levels were significantly increased in both erosive RA groups compared with non-erosive diseases, whether RA or ReA (P\u2003&amp;lt;\u20030\u00b705), whose SF levels were not different. SF IL-10 showed a similar profile to that of SF sCD23 and was the only other parameter characteristic of erosive RA, but no direct correlation was found between the two. SF sCD23 was significantly correlated with IL-12 (r = 0\u00b765, P = 0\u00b70001) and sCD25 (r = 0\u00b739, P = 0\u00b70019) exclusively in the two erosive RA populations. In conclusion, these data showing that increased levels of sCD23 are not only found in the SF of erosive joints but also in knee SF of patients with erosive RA but without knee x-ray-diagnosed erosions suggest that this parameter might be of predictive value for joint destruction. Longitudinal studies are however needed to confirm its potential clinical interest.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2000.01198.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:20:51Z","timestamp":1047378051000},"page":"194-199","source":"Crossref","is-referenced-by-count":18,"title":["Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA)"],"prefix":"10.1093","volume":"120","author":[{"given":"C","family":"Ribbens","sequence":"first","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Bonnet","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Andre","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Kaye","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Franchimont","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"De Groote","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Beguin","sequence":"additional","affiliation":[{"name":"Haematology Departments, CHU Sart-Tilman B35, University of Li\u00e8ge, Li\u00e8ge, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Malaise","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"2022011316464795400_b1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0065-2776(08)60776-2","article-title":"Expression, structure and function of the CD23 antigen","volume":"49","author":"Delespesse","year":"1991","journal-title":"Adv Immunol"},{"key":"2022011316464795400_b2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-065X.1992.tb00626.x","article-title":"The low-affinity receptor for IgE","volume":"125","author":"Delespesse","year":"1992","journal-title":"Immunol Rev"},{"key":"2022011316464795400_b3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02919132","article-title":"Expression, regulation and function of human Fc epsilon RII (CD23) antigen","volume":"11","author":"Sarfati","year":"1992","journal-title":"Immunol Res"},{"key":"2022011316464795400_b4","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/eji.1830210504","article-title":"Recombinant 25-kDa CD23 and interleukin 1\u03b1 promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis","volume":"21","author":"Liu","year":"1991","journal-title":"Eur J Immunol"},{"key":"2022011316464795400_b5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2249.1991.tb05720.x","article-title":"Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases","volume":"85","author":"Matsumo","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011316464795400_b6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1182\/blood.V71.1.94.94","article-title":"Elevation of IgE-binding factors in serum patients with B-cell-derived chronic lymphocytic leukemia","volume":"71","author":"Sarfati","year":"1988","journal-title":"Blood"},{"key":"2022011316464795400_b7","first-page":"2019","article-title":"Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia","volume":"7","author":"Beguin","year":"1993","journal-title":"Leukemia"},{"key":"2022011316464795400_b8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.1992.tb06979.x","article-title":"Soluble CD23 levels are elevated in the serum of patients with primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus","volume":"89","author":"Bansal","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"2022011316464795400_b9","first-page":"285","article-title":"Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity","volume":"79","author":"Bansal","year":"1993","journal-title":"Immunology"},{"key":"2022011316464795400_b10","first-page":"711","article-title":"Increased soluble CD23 molecules in serum\/saliva and correlation with the stage of sialoectasis in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Takei","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2022011316464795400_b11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02505047","article-title":"Elevated soluble CD23 levels in the sera from patients with localized scleroderma","volume":"288","author":"Sato","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"2022011316464795400_b12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-2478(96)02612-0","article-title":"Serum soluble CD23 levels in giant cell arteritis","volume":"53","author":"Roblot","year":"1996","journal-title":"Immunol Letters"},{"key":"2022011316464795400_b13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/08916939809003863","article-title":"Plasma and synovial fluid soluble CD23 concentrations in children with juvenile chronic arthritis","volume":"27","author":"Kutukculer","year":"1998","journal-title":"Autoimmunity"},{"key":"2022011316464795400_b14","first-page":"611","article-title":"Serum soluble CD23 levels and CD23 expression on peripheral blood mononuclear cells in juvenile chronic arthritis","volume":"16","author":"Massa","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"2022011316464795400_b15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/art.1780360215","article-title":"Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4","volume":"36","author":"Chomarat","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2022011316464795400_b16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000236485","article-title":"Possible role of CD5+ B cells expressing CD23 in mediating elevation of serum-soluble CD23 in patients with rheumatoid arthritis","volume":"101","author":"Izikawa","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"2022011316464795400_b17","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/clin.1994.1066","article-title":"Impaired release of sCD23 by activated B-cells from RA patients","volume":"71","author":"Rezonzew","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011316464795400_b18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/rheumatology\/38.4.325","article-title":"CD5 and CD23 expression on B cells in peripheral blood and synovial fluid of rheumatoid arthritis: relationship with interleukin-4, soluble CD23 and tumor necrosis factor alpha levels","volume":"38","author":"Loza","year":"1999","journal-title":"Rheumatol"},{"key":"2022011316464795400_b19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/clin.1994.1148","article-title":"CD23 hyperexpression in rheumatoid arthritis: evidence for a B cell hyperresponsiveness to cognate and noncognate T-cell signals","volume":"72","author":"Fernandez-Gutierrez","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011316464795400_b20","first-page":"281","article-title":"Increased levels of sCD23 in rheumatoid arthritis are related to disease status","volume":"12","author":"Bansal","year":"1994","journal-title":"Clin Exp Rheumatol"},{"key":"2022011316464795400_b21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/jcp.44.4.293","article-title":"Immunohistochemical demonstration of CD23 expression on lymphocytes in rheumatoid synovitis","volume":"44","author":"Hellen","year":"1991","journal-title":"J Clin Pathol"},{"issue":"Suppl. 2","key":"2022011316464795400_b22","first-page":"110","article-title":"Soluble CD23 expression in patients with rheumatoid arthritis","volume":"30","author":"Roussou","year":"1991","journal-title":"Br J Rheumatol"},{"key":"2022011316464795400_b23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.180.3.1005","article-title":"Regulation of cytokine production by soluble CD23: costimulation of interferon \u03b3 secretion and triggering of tumor necrosis factor \u03b1 release","volume":"180","author":"Armant","year":"1994","journal-title":"J Exp Med"},{"key":"2022011316464795400_b24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/1074-7613(95)90164-7","article-title":"CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18","volume":"3","author":"Lecoanet-Henchoz","year":"1995","journal-title":"Immunity"},{"key":"2022011316464795400_b25","first-page":"518","article-title":"Highly increased levels of tumor necrosis factor-\u03b1 and other proinflammatory cytokines in psoriatic arthritis synovial fluid","volume":"24","author":"Partsch","year":"1997","journal-title":"J Rheumatol"},{"key":"2022011316464795400_b26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm0895-781","article-title":"Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo","volume":"1","author":"Plater-Zyberk","year":"1995","journal-title":"Nature Med"},{"key":"2022011316464795400_b27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2022011316464795400_b28","first-page":"406","article-title":"Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis","volume":"22","author":"Steiner","year":"1995","journal-title":"J Rheumatol"},{"key":"2022011316464795400_b29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/028418517701800415","article-title":"Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films","volume":"18","author":"Larsen","year":"1977","journal-title":"Acta Radiol Diagn"},{"key":"2022011316464795400_b30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0167-5699(96)10054-2","article-title":"A new role for CD23 in inflammation","volume":"17","author":"Bonnefoy","year":"1996","journal-title":"Immunol Today"},{"key":"2022011316464795400_b31","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.4049\/jimmunol.162.7.4266","article-title":"Importance of CD23 for collagen-induced arthritis: delayed onset and reduced severity in CD23-deficient mice","volume":"162","author":"Kleinau","year":"1999","journal-title":"J Immunol"},{"key":"2022011316464795400_b32","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/ard.45.8.684","article-title":"Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis","volume":"45","author":"Walker","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"2022011316464795400_b33","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/eji.1830261219","article-title":"Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice","volume":"26","author":"McIntyre","year":"1996","journal-title":"Eur J Immunol"},{"key":"2022011316464795400_b34","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1073\/pnas.92.11.4823","article-title":"Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA\/1 mice","volume":"92","author":"Germann","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011316464795400_b35","first-page":"473","article-title":"Regulation of CD23 expression, soluble CD23 release and immunoglobulin synthesis of peripheral blood lymphocytes by glucocorticoids","volume":"71","author":"Fischer","year":"1990","journal-title":"Immunology"},{"key":"2022011316464795400_b36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.1780371114","article-title":"In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sj\u00f6gren\u2019s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity","volume":"37","author":"Llorente","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2022011316464795400_b37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.1780380115","article-title":"Elevated interleukin-10 levels in patients with rheumatoid arthritis","volume":"38","author":"Cush","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2022011316464795400_b38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.1996.tb08288.x","article-title":"Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)","volume":"103","author":"Bucht","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2022011316464795400_b39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.1780390306","article-title":"Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium","volume":"39","author":"Isom\u00e4ki","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2022011316464795400_b40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00918147","article-title":"Biological properties of interleukin 10","volume":"12","author":"Howard","year":"1992","journal-title":"J Clin Immunol"},{"key":"2022011316464795400_b41","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1073\/pnas.89.5.1890","article-title":"Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes","volume":"89","author":"Rousset","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011316464795400_b42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0889-857X(05)70030-2","article-title":"IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis","volume":"24","author":"Keystone","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl.","key":"2022011316464795400_b43","first-page":"S224","article-title":"rHuIL-10 in subjects with active rheumatoid arthritis (RA): a phase I and cytokine response study","volume":"40","author":"Maini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2022011316464795400_b44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF01541668","article-title":"IL-10 suppresses cell surface CD23\/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes","volume":"16","author":"Morinobu","year":"1996","journal-title":"J Clin Immunol"},{"key":"2022011316464795400_b45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2249.1991.tb05682.x","article-title":"Detection of circulating Fc\u03b5R2\/CD23+ monocytes in patients with rheumatic diseases","volume":"85","author":"Becker","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011316464795400_b46","first-page":"284","article-title":"Predictive value of synovial fluid analysis in rheumatoid arthritis. A 7.5-year follow-up study","volume":"2","author":"Luukkainen","year":"1993","journal-title":"Eur J Med"},{"key":"2022011316464795400_b47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/ard.58.9.559","article-title":"The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study","volume":"58","author":"Aman","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"2022011316464795400_b48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF01782262","article-title":"Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor \u03b1 in the knee-joints of patients with rheumatoid arthritis","volume":"44","author":"Neidel","year":"1995","journal-title":"Inflamm Res"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01198.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01198.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/120\/1\/194\/42182976\/j.1365-2249.2000.01198.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/120\/1\/194\/42182976\/j.1365-2249.2000.01198.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T07:38:01Z","timestamp":1704785881000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/120\/1\/194\/6461703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,12,24]]},"published-print":{"date-parts":[[2001,12,24]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01198.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,4]]},"published":{"date-parts":[[2000,4]]}}}